Detailed information for compound 174036

Basic information

Technical information
  • TDR Targets ID: 174036
  • Name: 4-[(E)-2-(1-methyl-7-propan-2-ylazulen-4-yl)e thenyl]benzoic acid
  • MW: 330.42 | Formula: C23H22O2
  • H donors: 1 H acceptors: 2 LogP: 6.19 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: CC(c1ccc(c2c(c1)c(C)cc2)/C=C/c1ccc(cc1)C(=O)O)C
  • InChi: 1S/C23H22O2/c1-15(2)20-12-11-18(21-13-4-16(3)22(21)14-20)8-5-17-6-9-19(10-7-17)23(24)25/h4-15H,1-3H3,(H,24,25)/b8-5+
  • InChiKey: JSONZTQVAAXXKF-VMPITWQZSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 4-[(E)-2-(7-isopropyl-1-methyl-azulen-4-yl)vinyl]benzoic acid
  • 4-[(E)-2-(7-isopropyl-1-methyl-4-azulenyl)vinyl]benzoic acid
  • 4-[(E)-2-(1-methyl-7-propan-2-yl-azulen-4-yl)ethenyl]benzoic acid

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Entamoeba histolytica FKBP-rapamycin associated protein (FRAP), putative 0.1859 1 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.1113 0.5489 0.5419
Trichomonas vaginalis PIKK family atypical protein kinase 0.1005 0.4835 0.4754
Trichomonas vaginalis phopsphatidylinositol 3-kinase, drosophila, putative 0.0313 0.0652 0.0506
Trichomonas vaginalis phosphatidylinositol kinase, putative 0.0313 0.0652 0.0506
Trichomonas vaginalis conserved hypothetical protein 0.0271 0.0396 0.0246
Trichomonas vaginalis PIKK family atypical protein kinase 0.148 0.7707 0.7671
Trichomonas vaginalis PIKK family atypical protein kinase 0.1007 0.4844 0.4763
Trypanosoma cruzi target of rapamycin kinase 3 0.1482 0.7716 0.768
Echinococcus multilocularis phosphatidylinositol 4,5 bisphosphate 3 kinase 0.0484 0.1685 0.1481
Trichomonas vaginalis PIKK family atypical protein kinase 0.1102 0.5423 0.5351
Echinococcus granulosus serine:threonine protein kinase SMG1 0.0356 0.0912 0.0689
Trichomonas vaginalis PIKK family atypical protein kinase 0.1005 0.4835 0.4754
Echinococcus multilocularis serine protein kinase ATM 0.0356 0.0912 0.0689
Brugia malayi FAT domain containing protein 0.0271 0.0396 0.016
Trichomonas vaginalis PIKK family atypical protein kinase 0.0627 0.2551 0.2434
Trichomonas vaginalis PIKK family atypical protein kinase 0.0356 0.0912 0.077
Trichomonas vaginalis phosphatidylinositol 3-kinase class, putative 0.0253 0.0285 0.0133
Trichomonas vaginalis PIKK family atypical protein kinase 0.1007 0.4844 0.4763
Trichomonas vaginalis PIKK family atypical protein kinase 0.1384 0.7128 0.7083
Trypanosoma cruzi phosphatidylinositol kinase related protein, putative 0.0356 0.0912 0.077
Trichomonas vaginalis phosphatidylinositol 3-kinase catalytic subunit alpha, beta, delta, putative 0.0253 0.0285 0.0133
Trichomonas vaginalis PIKK family atypical protein kinase 0.1384 0.7128 0.7083
Leishmania major target of rapamycin (TOR) kinase 2, putative 0.1859 1 1
Entamoeba histolytica Phosphatidylinositol 3- and 4-kinase family 0.0356 0.0912 0.0912
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.0356 0.0912 0.0689
Trichomonas vaginalis PIKK family atypical protein kinase 0.0356 0.0912 0.077
Trichomonas vaginalis PIKK family atypical protein kinase 0.148 0.7707 0.7671
Loa Loa (eye worm) hypothetical protein 0.0245 0.0239 0.0087
Trypanosoma cruzi phosphatidylinositol 3-related kinase, putative 0.0627 0.2551 0.2434
Entamoeba histolytica phosphatidylinositol 3-kinase, putative 0.0313 0.0652 0.0652
Trypanosoma brucei phosphatidylinositol 3-related kinase, putative 0.0627 0.2551 0.1803
Trichomonas vaginalis PIKK family atypical protein kinase 0.1859 1 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0503 0.1799 0.1671
Echinococcus granulosus serine protein kinase ATM 0.0356 0.0912 0.0689
Echinococcus multilocularis PIK kinase, FAT and Armadillo domain containing protein 0.0271 0.0396 0.016
Trichomonas vaginalis PIKK family atypical protein kinase 0.148 0.7707 0.7671
Trichomonas vaginalis PIKK family atypical protein kinase 0.0627 0.2551 0.2434
Trypanosoma brucei Phosphatidylinositol 3-kinase tor1 0.1859 1 1
Trypanosoma brucei phosphatidylinositol 3-kinase, putative 0.0627 0.2551 0.1803
Entamoeba histolytica protein kinase rad3, putative 0.0356 0.0912 0.0912
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.0627 0.2551 0.2368
Trichomonas vaginalis PIKK family atypical protein kinase 0.1113 0.5489 0.5419
Schistosoma mansoni phosphatidylinositol 3-and 4-kinase 0.0627 0.2551 0.2243
Trypanosoma cruzi phosphatidylinositol 3-related kinase, putative 0.0627 0.2551 0.2434
Giardia lamblia GTOR 0.1859 1 1
Trypanosoma cruzi phosphatidylinositol 3-kinase, putative 0.0356 0.0912 0.077
Entamoeba histolytica phosphatidylinositol3-kinaseTor2, putative 0.1859 1 1
Trypanosoma brucei FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative 0.0776 0.3447 0.279
Trichomonas vaginalis PIKK family atypical protein kinase 0.0627 0.2551 0.2434
Trichomonas vaginalis conserved hypothetical protein 0.0396 0.1154 0.1016
Trichomonas vaginalis phosphatidylinositol 3-kinase catalytic subunit gamma, putative 0.0313 0.0652 0.0506
Toxoplasma gondii non-specific serine/threonine protein kinase 0.0396 0.1154 0.039
Trypanosoma cruzi Phosphatidylinositol 3-kinase tor2 0.1859 1 1
Trypanosoma cruzi Phosphatidylinositol 3-kinase tor1 0.1859 1 1
Echinococcus multilocularis FKBP12 rapamycin complex associated protein 0.1859 1 1
Trypanosoma brucei target of rapamycin kinase 3, putative 0.1482 0.7716 0.7487
Echinococcus granulosus phosphatidylinositol 45 bisphosphate 3 kinase 0.0484 0.1685 0.1481
Entamoeba histolytica phosphatidylinositol 3-kinase, putative 0.0274 0.0413 0.0413
Loa Loa (eye worm) phosphatidylinositol 3 0.0627 0.2551 0.2434
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.0356 0.0912 0.0689
Loa Loa (eye worm) phosphatidylinositol 3 0.1859 1 1
Loa Loa (eye worm) hypothetical protein 0.0356 0.0912 0.077
Loa Loa (eye worm) hypothetical protein 0.0396 0.1154 0.1016
Loa Loa (eye worm) hypothetical protein 0.0271 0.0396 0.0246
Trichomonas vaginalis PIKK family atypical protein kinase 0.1209 0.6068 0.6006
Entamoeba histolytica hypothetical protein 0.0274 0.0413 0.0413
Leishmania major target of rapamycin (TOR) kinase 1, putative 0.1859 1 1
Echinococcus granulosus phosphatidylinositol 3 and 4 kinase 0.0627 0.2551 0.2368
Schistosoma mansoni fkbp-rapamycin associated protein 0.0356 0.0912 0.0537
Trichomonas vaginalis PIKK family atypical protein kinase 0.1384 0.7128 0.7083
Echinococcus multilocularis phosphatidylinositol 3 and 4 kinase 0.0627 0.2551 0.2368
Schistosoma mansoni phosphatidylinositol-45-bisphosphate 3-kinase catalytic subunit alpha PI3K 0.0484 0.1685 0.1342
Trichomonas vaginalis PIKK family atypical protein kinase 0.1384 0.7128 0.7083
Trichomonas vaginalis PIKK family atypical protein kinase 0.1113 0.5489 0.5419
Trichomonas vaginalis PIKK family atypical protein kinase 0.1005 0.4835 0.4754
Trichomonas vaginalis PIKK family atypical protein kinase 0.1102 0.5423 0.5351
Toxoplasma gondii target of rapamycin (TOR), putative 0.1384 0.7128 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0627 0.2551 0.2434
Leishmania major target of rapamycin kinase (TOR) kinase 3 0.1482 0.7716 0.6934
Trypanosoma cruzi phosphatidylinositol 3-kinase 2, putative 0.0313 0.0652 0.0506
Schistosoma mansoni ataxia telangiectasia mutated (atm) 0.0356 0.0912 0.0537
Trichomonas vaginalis PIKK family atypical protein kinase 0.1249 0.631 0.6252
Trichomonas vaginalis PIKK family atypical protein kinase 0.1384 0.7128 0.7083
Trichomonas vaginalis PIKK family atypical protein kinase 0.148 0.7707 0.7671
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.0313 0.0652 0.0423
Trichomonas vaginalis PIKK family atypical protein kinase 0.1007 0.4844 0.4763
Trichomonas vaginalis PIKK family atypical protein kinase 0.0356 0.0912 0.077
Echinococcus multilocularis serine:threonine protein kinase SMG1 0.0356 0.0912 0.0689
Entamoeba histolytica hypothetical protein 0.0356 0.0912 0.0912
Trichomonas vaginalis PIKK family atypical protein kinase 0.1384 0.7128 0.7083
Trichomonas vaginalis PIKK family atypical protein kinase 0.1007 0.4844 0.4763
Echinococcus granulosus PIK kinase FAT and Armadillo domain containing protein 0.0271 0.0396 0.016
Trichomonas vaginalis PIKK family atypical protein kinase 0.1384 0.7128 0.7083
Echinococcus granulosus FKBP12 rapamycin complex associated protein 0.1859 1 1
Trypanosoma brucei phosphatidylinositol 3-kinase tor, putative 0.0882 0.4092 0.35
Trichomonas vaginalis PIKK family atypical protein kinase 0.148 0.7707 0.7671
Trichomonas vaginalis PIKK family atypical protein kinase 0.1859 1 1
Trypanosoma brucei phosphatidylinositol 4-kinase, putative 0.1859 1 1
Loa Loa (eye worm) phosphatidylinositol 3 0.0445 0.1445 0.1312
Trichomonas vaginalis PIKK family atypical protein kinase 0.1859 1 1
Schistosoma mansoni ataxia telangiectasia mutated (atm)-related 0.1859 1 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0627 0.2551 0.2434
Trypanosoma cruzi phosphatidylinositol 3-kinase 2, putative 0.0313 0.0652 0.0506
Trichomonas vaginalis PIKK family atypical protein kinase 0.1588 0.8361 0.8336
Loa Loa (eye worm) hypothetical protein 0.0378 0.1041 0.0901

Activities

Activity type Activity value Assay description Source Reference
Communicating cells (functional) = 9.5 Tested for anticancer activity by measuring the number of communicating cells using gap junctional communication assay at 10e-6 M (P>0.001) ChEMBL. 8230100
Control (functional) = 0 % Inhibition of neoplastic transformation at a concentration of 10e-6 M ChEMBL. 8230100
Control (functional) = 0 % Inhibition of neoplastic transformation at a concentration of 10e-6 M ChEMBL. 8230100
Control (functional) = 24 % Inhibition of neoplastic transformation at a concentration of 10e-8 M ChEMBL. 8230100
Control (functional) = 24 % The compound was tested for inhibition of neoplastic transformation,at a concentration of 10e-10 M ChEMBL. 8230100
Control (functional) = 24 % Inhibition of neoplastic transformation at a concentration of 10e-8 M ChEMBL. 8230100
Control (functional) = 24 % The compound was tested for inhibition of neoplastic transformation,at a concentration of 10e-10 M ChEMBL. 8230100
Control (functional) = 66 % Tested for toxicity against C3H10T1/2 cell line of murine embryo fibroblasts at 10e-6 M ChEMBL. 8230100
Control (functional) = 66 % Tested for toxicity against C3H10T1/2 cell line of murine embryo fibroblasts at 10e-6 M ChEMBL. 8230100
Control (functional) = 75 % Tested for toxicity against C3H10T1/2 cell line of murine embryo fibroblasts at 10e-8 M ChEMBL. 8230100
Control (functional) = 75 % Toxicity against C3H10T1/2 cell line of murine embryo fibroblasts at 10e-10 M ChEMBL. 8230100
Control (functional) = 75 % Tested for toxicity against C3H10T1/2 cell line of murine embryo fibroblasts at 10e-8 M ChEMBL. 8230100
Control (functional) = 75 % Toxicity against C3H10T1/2 cell line of murine embryo fibroblasts at 10e-10 M ChEMBL. 8230100
Foci/dish (functional) = 0 Inhibition of neoplastic transformation was measured by measuring the transformed foci per dish at 10e-6 M ChEMBL. 8230100
Foci/dish (functional) = 0.16 Tested for inhibition of neoplastic transformation by measuring the transformed foci per dish at 10e-8 M ChEMBL. 8230100
Foci/dish (functional) = 0.16 Tested for inhibition of neoplastic transformation by measuring the transformed foci per dish at 10e-10 M ChEMBL. 8230100

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.